Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

ALKS 54.57 -0.98 (-1.76%)
price chart
Alkermes Plc (ALKS) Q4 2016 Results - Earnings Call Transcript
Good morning, and welcome to the Alkermes' Fourth Quarter and Year End 2016 Financial Results. My name is Brandon, and I'll be your operator for today.
Alkermes plc (ALKS) Tops Q4 EPS by 11c  StreetInsider.com
Alkermes plc (ALKS) Moves Higher on Volume Spike for February 14  Equities.com
Analyst Activity – Cantor Fitzgerald Reiterates Neutral on Alkermes PLC ...
The current consensus rating on Alkermes PLC (NASDAQ:ALKS) is Buy (Score: 2.70) with a consensus target price of $61.36 per share, a potential 7.86% upside.
Alkermes plc (ALKS): Looking to 2018 - Cantor Fitzgerald  StreetInsider.com
Alkermes PLC (ALKS) Issues Quarterly Earnings Results  Sports Perspectives
Why Alkermes PLC Skyrocketed Today
Alkermes tested ALKS 5461 in patients with major depressive disorder who haven't been helped by other drugs. At the higher dose, ALKS 5461 improved symptoms of depression -- based on two different scales used by doctors -- compared with placebo.
Credit Suisse Bullish on Alkermes Plc (ALKS) as It Takes a Leap FORWARD  Smarter Analyst
Alkermes Surge by a Record 47% on Depression Pill Trial Success  Bloomberg
Alkermes PLC: Sales Rise, Losses Fall, and the Pipeline Moves Forward
Alkermes (NASDAQ:ALKS), a biopharmaceutical company that specializes in extended-release drug delivery technology, reported third-quarter results on Nov. 2 and provided investors with an update on its pipeline.
PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union ...
PRIMECAP Management added to the holdings in Alkermes PLC by 102.19%. The purchase prices were between $42.3 and $59.5, with an estimated average price of $53.46.
Alkermes Plc (ALKS) Richard Pops on Q2 2016 Results - Earnings Call Transcript
Good morning ladies and gentlemen, and thank you for standing by. Welcome to the Alkermes Conference Call to discuss the Company's Second Quarter Financial Results.
Alkermes plc Reports Second Quarter 2016 Financial Results  Business Wire (press release)
Alkermes (ALKS) Posts Narrower Q2 Loss, Ups 2016 Outlook  Zacks.com
Alkermes plc (ALKS) Moves Higher on Volume Spike for February 10
Alkermes plc (ALKS) traded on unusually high volume on Feb. 10, as the stock gained 1.18% to close at $55.11. On the day, Alkermes plc saw 1.16 million shares trade hands on 7,544 trades. Considering that the stock averages only a daily volume of ...
The 8000 Shares in Alkermes PLC (ALKS) Acquired by Sicart Associates LLC  DailyQuint
The Alkermes PLC (ALKS) Scheduled to Post Quarterly Earnings on Wednesday
Alkermes PLC (NASDAQ:ALKS) is scheduled to be announcing its Q416 earnings results on Wednesday, February 15th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $206.38 million for the quarter.
Alkermes PLC (ALKS) Rating Increased to C at TheStreet  The Cerbat Gem
Alkermes PLC's (ALKS) Neutral Rating Reaffirmed at Cantor Fitzgerald  Sports Perspectives
Analyst Upgrades: Alkermes Plc, Chesapeake Energy Corporation, and Paypal ...
Analysts are weighing in on biotech Alkermes Plc (NASDAQ:ALKS), natural gas producer Chesapeake Energy Corporation (NYSE:CHK), and digital payments stock Paypal Holdings Inc (NASDAQ:PYPL).
Alkermes plc (ALKS) Moves Higher on Volume Spike for February 01
Alkermes plc (ALKS) traded on unusually high volume on Feb. 01, as the stock gained 1.09% to close at $54.70. On the day, Alkermes plc saw 1.26 million shares trade hands on 10,865 trades. Considering that the stock averages only a daily volume of ...
Large Outflow of Money Witnessed in Alkermes plc  Morning Outlook